LaurenH

Administrators
  • Content count

    298
  • Joined

  • Last visited

  • Days Won

    12

LaurenH last won the day on June 24

LaurenH had the most liked content!

About LaurenH

  • Rank
    MODERATOR
  • Birthday 10/18/1985

Profile Information

  • Gender
    Female
  • US State
    MARYLAND
  • Status
    No
  • Interests
    Social Media, Running, Yoga, Reading, Traveling, Cooking

Recent Profile Visitors

1,115 profile views
  1. Hi, Laura, I am very sorry that you and your husband are going through this, but we are glad that you've joined this community. Please continue to post updates and feel free to ask questions. The more information you can share, the easier it will be for us to connect you to resources and people who may be able to help you navigate his diagnosis. With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation
  2. If you have been diagnosed with NSCLC and would like to learn more about a marketing research study being conducted through Baltimore Research, please see the attached flyer. NSCLC Patients flyer.pdf
  3. Here is the weekly clip report: Genetic Engineering and Biotechnology News “Discovery of New Immune Cell May Improve Treatment of Lung Cancer Patients” http://www.genengnews.com/gen-news-highlights/discovery-of-new-immune-cell-may-improve-treatment-of-lung-cancer-patients/81254527 Specialty Pharmacy Times “Alectinib Slashes Risk of Disease Progression or Death by Half in Patients with NSCLC” https://www.specialtypharmacytimes.com/news/alectinib-slashes-risk-of-disease-progression-or-death-by-half-in-patients-with-nsclc Cancer Network “ASTRO Issued New Guideline on Use of SBRT in Early-Stage Lung Cancer” http://www.cancernetwork.com/news/astro-issued-new-guideline-use-sbrt-early-stage-lung-cancer Radiology Business “Dozens of House Members Caution against Further Cuts to Lung Screening Reimbursement” http://www.radiologybusiness.com/topics/policy/dozens-house-members-caution-against-further-cuts-lung-screening-reimbursement Targeted Oncology “The Debate over Upfront Use of Newer Targeted Agents in NSCLC” http://www.targetedonc.com/publications/targeted-therapy-news/2017/June-2017/the-debate-over-upfront-use-of-newer-targeted-agents-in-nsclc Genome Web “In Efforts to Ramp Up Adoption of Liquid Biopsies, Lung Cancer Becomes Proving Ground” https://www.genomeweb.com/molecular-diagnostics/efforts-ramp-adoption-liquid-biopsies-lung-cancer-becomes-proving-ground Mayo Clinic News Network “Blood-Based Lung Cancer Test Shows Promise: Mayo Clinic Radio Health Minute” http://newsnetwork.mayoclinic.org/discussion/blood-based-lung-cancer-test-shows-promise-mayo-clinic-radio-health-minute/ Cancer Network “Atezolizumab Active in Advanced Lung Cancer, PD-L1 Predicts Response” http://www.cancernetwork.com/lung-cancer/atezolizumab-active-advanced-lung-cancer-pd-l1-predicts-response Harvard Business Review “New Approach to Safely Sharing Cancer Patients’ Data” https://hbr.org/2017/06/a-new-approach-to-safely-sharing-cancer-patients-data Cancer Therapy Advisor “Once-Daily Radiotherapy Not Superior to Twice-Daily in SCLC” http://www.cancertherapyadvisor.com/lung-cancer/lung-cancer-sclc-radiotherapy-superior-twice-daily/article/670091/ Medical Xpress “Catching Cancer Earlier—a New Frontier for Early Detection Research” https://medicalxpress.com/news/2017-06-cancer-earliera-frontier-early.html Lung Cancer News Today “Entinostat-Keytruda Clinical Trial in NSCLC Will Proceed to Next Stage” https://lungcancernewstoday.com/2017/06/22/entinostat-keytruda-clinical-trial-nsclc-proceed-next-stage/ Medical Xpress “First-Line Immunotherapy Treatment Can Improve Survival for Subset of Lung Cancer Patients” https://medicalxpress.com/news/2017-06-first-line-immunotherapy-treatment-survival-subset.html PR Newswire “FDA Approves First Companion Diagnostic Test to Simultaneously Screen for Multiple Non-Small Cell Lung Cancer Therapies” http://www.prnewswire.com/news-releases/fda-approves-first-companion-diagnostic-test-to-simultaneously-screen-for-multiple-non-small-cell-lung-cancer-therapies-300478690.html Cure Today “Combination Approved for BRAF-Positive Lung Cancer” http://www.curetoday.com/articles/combination-approved-for-braf-positive-lung-cancer Healio “10 Updates in Immunotherapy Research” https://www.healio.com/hematology-oncology/lung-cancer/news/online/{4f336a9e-848e-49d8-8fe1-a43d04bbce72}/10-updates-in-immunotherapy-research
  4. That's good to hear, Julie! Please keep us posted! With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation
  5. Great news, Vicky! I'm so happy to hear positive results. With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation
  6. Hi, Steff, I am sorry that you and your family are going through this again. Tom is a great example of a long term survivor who has lived through recurrences. Please keep us posted on your mom's surgery and biopsy. Once we have more information, we can connect you to others with a similar diagnosis. We have many resources for patients/survivors and caregivers, so please let me know if you'd like to learn more about our support program. We are here for you. With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation
  7. Join Cancer Legal Resource Center tomorrow at 12:00 PM PT for the second webinar in our 2017 series. In this webinar, we will give an overview of the laws that provide protection in the workplace for those who are coping with a cancer diagnosis, including the Americans with Disabilities Act, state fair employment laws, the Family and Medical Leave Act, and other resources. Click here for more information, and to register online. This post was approved by LUNGevity.
  8. Trialbee is recruiting for a clinical study to evaluate an investigative treatment for Lung Neuroendocrine Tumors (Lung NETs). You may have heard of this condition being called Lung Carcinoid Tumors, Bronchial NETs, or Pulmonary NETs. A total of 216 patients will be a part of this global study, which has been approved by the FDA and relevant ethics committees. We are looking for both males and females, aged 18 years or older, who are diagnosed with a neuroendocrine tumor of the lung (Lung NET). To find out if the study may be suitable for you, please visit this website. This post has been approved by LUNGevity Foundation.
  9. Thank you, Julie and Tom! Lauren -- Digital Community Manager LUNGevity Foundation
  10. Did you know 41 percent of Americans have never viewed their health data? As a member of LUNGevity online patient groups you may be many steps ahead of the average American patient or caregiver! Telling us about your experience accessing your own or a loved one's health data will help shape a new project being led by FasterCures, a nonprofit organization that works across diseases to smooth speed bumps that slow down the process of getting promising therapies to patients. We invite you to learn more about our new Health Data Basics project and to respond to a short anonymous survey. Your input will help us develop a new tool to inform people about health data access, sharing and use. Click here to learn more and take the survey! The link of the survey is: https://www.surveymonkey.com/r/PK29LR5 And contact information for the project is: https://www.healthdatabasics.org/contact/
  11. Hi, JustMe, I will reach out to some of our members and encourage anyone who has information/experience to respond! Lauren -- Digital Community Manager LUNGevity Foundation
  12. Mally, I am so happy for you!! Congratulations! We are glad that you're such an active member of the community and we are grateful to be able to celebrate with you! Lauren -- Digital Community Manager LUNGevity Foundation
  13. Hi, Marcie, You and your dad are in our thoughts this week. Please post an update when you can. No matter what his official diagnosis is, we are here for you! With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation
  14. Hi, Dave, Thanks for posting an update. Sounds like you've been handling everything like a...Dragon King! Stay positive. We are here for you. With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation
  15. Hi

    Hi, Shell, Welcome to LCSC. I am sorry to hear about your friend's diagnosis. There are many caregivers on this site. I will reach out to them and encourage them to connect with you in this thread. You can find several helpful resources in the online Caregiver Resource Center. LUNGevity also offers peer-to-peer support for caregivers through the LifeLine Support Mentor Program. Please let me know if you would like more information! We are here for you! With gratitude, Lauren -- Digital Community Manager LUNGevity Foundation